About PSA Testing

Sunday, April 5, 2009

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Developed by RPCI cancer scientists, the PSA test is used around the world to detect prostate cancer in its earliest, most treatable form. Dr. James Mohler, Chair of the Department of Urologic Oncology and prostate cancer survivor, Otis Cowart offer insights into the PSA test.

Cancer Talk Blog

May is National Brain Tumor Awareness Month. To help you begin to understand this complex group of tumors, we have compiled some of the key facts, statistics and information below. Learn about the Neuro-oncology Center at Roswell Park or consult the links and sources below for more information. Brain Tumor Facts and Figures

Ask A Question

Do you have a cancer question you’d like RPCI cancer experts to address? Submit a topic for consideration.

close